Media-no-image

INSIGHTRA MEDICAL AND NOVUS SCIENTIFIC ANNOUNCE A STRATEGIC ALLIANCE AROUND TIGR® MATRIX SURGICAL MESH TECHNOLOGY

Press Releases   •   Nov 30, 2015 10:00 GMT

Press Release November 30, 2015:

Insightra Medical, Inc. and Novus Scientific AB have announced a strategic alliance around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair in the US via Insightra’s national direct sales channel.

Made from synthetic polymers, TIGR® Matrix is a long-term resorbable surgical mesh intended to support and reinforce soft tissue for 6-9 months before absorbing completely after 3 years. It has been FDA cleared since 2010 and is available in three sizes.

“In the quest to become a full-line hernia technology supplier, adding TIGR® Matrix to our portfolio fills an important void in our offering. Having both high-end synthetics and biologics, TIGR® Matrix fills the gap between the two,” says Brad Sharp, CEO at Insightra Medical.

“We are very pleased to be working in the US with Insightra around our TIGR® Matrix technology, given their focus on hernia and soft tissue repair. Insightra’s dedication to promoting technology that reduces pain and other known complications in soft tissue repair caught our attention from the beginning,” says Stefan Sowa, CEO at Novus Scientific.

TIGR® Matrix has gained positive feedback and been well reviewed in publications from numerous hernia specialists. The most recent scientific publication reported the successful use of TIGR® Matrix in 63 patients in complex abdominal wall repair where it demonstrated surgical outcomes similar to biologic mesh implants typically used in these kinds of procedure, but at a decreased cost.1

Bruce Ramshaw, MD, Chair of Department of Surgery at the University of Tennessee Graduate School of Medicine in Knoxville, has used TIGR® Matrix since 2011. Dr. Ramshaw explains: “Applying the principles of value-based Clinical Quality Improvement, we used TIGR® Matrix for patients who undergo complex Abdominal Wall Reconstruction (AWR). By replacing the biologic meshes we previously used for AWR, we saw significant savings for the hospital and when combined with other process improvement ideas, we saw better outcomes.”

As foundation partner of the Americas Hernia Society Quality Collaborative (AHSQC), Insightra Medical encourages all surgeons to enter their use of hernia implants into this registry to improve patient outcome.

About Insightra Medical

Insightra Medical, Inc. designs, develops and markets a new generation of medical devices serving the hernia and general surgery market. As a fast growing hernia device company with a dedicated hernia sales force in the United States. Insightra Medical is focused on improving patient outcomes such as reducing post-operative pain. For more information, please visit http://www.insightra.com.

About Novus Scientific

Novus Scientific AB, Uppsala, Sweden, develops, manufactures and markets resorbable implants that help the body’s own healing. For more information, please visit http://www.novusscientific.com

Contacts

Insightra Medical Inc.

Gayle Arnold, +1-949-215-1835

Novus Scientific AB

Stefan Sowa, +46 18 751 35 00

1.  Stephan B, et al. Value-based Clinical Quality Improvement (CQI) for Patients Undergoing Abdominal Wall Reconstruction; Surg Technol Int. 2015 May;26:135-42.

Insightra Medical, Inc. and Novus Scientific AB have announced a strategic alliance around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair in the US via Insightra’s national direct sales channel.

Read more »
Ogygfffo6c0oxo2gfeg4

First patient included in the study PREVMESH – prophylactic resorbable mesh in open abdominal surgery to prevent incisional hernia

Press Releases   •   Jun 15, 2015 15:00 GMT

Novus Scientific (Uppsala, Sweden) is pleased to announce the start of the randomized controlled multicenter study PREVMESH. The study aims at assessing whether a long-term resorbable mesh (TIGR®Matrix) placed onlay after open abdominal surgery decreases the rate of incisional hernias and wound dehiscence.

U5ymftktrunb89cct5zi

​Which patients are at risk for incisional hernias? New data presented at 1st World Conference on Abdominal Wall Hernia Surgery

Blog posts   •   May 12, 2015 15:47 GMT

Data presented from Swedish validated registries showing risk factors for burst abdomen and incisional hernias after open abdominal surgery. By combining such risk factors, the authors believe they will be able to define those patients at greater risk for wound complications and find out how to treat these patients.

Rqmmzyzc8dzidtfkukrs

​Study indicates TIGR Matrix surgical mesh is safe for use as parastomal hernia prevention despite severely contaminated field

Blog posts   •   May 07, 2015 16:00 GMT

Safety data presented at the 1st World Conference on Abdominal Wall Hernia Surgery in Milan. TIGR Matrix was used to prevent parastomal hernia in emergency stoma formation. TIGR Matrix was safe to use despite severely contaminated field in a large group of the patients.

Ucv2fxw1qpmrccq5bp0o

Data on the use of TIGR® Matrix in 63 patients with complex abdominal wall reconstruction (AWR) presented at the 1st World Conference on Abdominal Wall Hernia Surgery

Blog posts   •   Apr 28, 2015 22:00 GMT

Dr Bruce Ramshaw presented data from the clinical quality improvement (CQI) program at the 1st World Conference on Abdominal Wall Hernia Surgery in Milan. Several attempts at process improvement were implemented in one hernia program over a three-year period. This led to decreased costs and improved outcomes for patients who underwent abdominal wall reconstruction.

Rqmmzyzc8dzidtfkukrs

​Novus Scientific to showcase TIGR® Matrix and present supporting evidence at the First World Conference on Abdominal Wall Hernia Surgery, Milan, April 25-29, 2015

News   •   Apr 24, 2015 17:55 GMT

Novus Scientific, the Swedish-based creator of TIGR® Matrix Surgical Mesh, will be exhibiting at this five-day meeting, which is the first of its kind in the world.

Media-no-image

New progress in polymer mesh for breast cancer surgeries

Blog posts   •   Jan 26, 2015 17:43 GMT

In November more than 90 breast surgeons gathered in Birmingham to learn more about the iBRA study. The aim of the study is to prospectively collect data in implant-based reconstruction after breast cancer across the UK. The goal is to include data for more than 1000 women and in december data for more than 300 women were included. Dr Peter Schrenk presented his data for implant based reconstruction with TIGR Matrix.

T

The iBRA study commented in Medical plastic News.

Read more »
Yl9ey5kyfppjvvdosf1v

Novus Scientific Announces New Size of TIGR® Matrix Surgical Mesh

Press Releases   •   Dec 12, 2014 14:00 GMT

Novus Responds to Need for Mid-Sized Matrix in Breast Reconstruction

Znt6yxdxqcnmavhk4erl

Oncoplastic and Reconstructive Breast Surgery (ORBS) 10-11th of Oct 2014

Blog posts   •   Oct 13, 2014 19:41 GMT

Great interest for TIGR Matrix at the ORBS meeting

Rhzqvxriz3v92zmdic8v

Todd Heniford talks TIGR in Becker's GI and Endoscopy

Press Releases   •   Oct 10, 2014 13:00 GMT

Dr. Todd Heniford talked with Novus about the newest technology in synthetic surgical mesh and (see content of story) statistical analysis of abdominal wall surgeries. Mike Smith’s interview at AWR appears in ‘Becker’s’ journal. The 25th anniversary edition of Surgical Technology International, a leading industry publication, was released today sponsored by Novus Scientific available at ASPS.

Contacts 1 contact

  • Press Contact
  • Global Marketing Manager
  • Europe and Asia-Pacific
  • jan.hermansson@novusscientific.com
  • +46703778337
  • +46703778337

About TIGR® Matrix

TIGR® Matrix (www.TIGRmatrix.com) is an innovative resorbable synthetic surgical mesh.

Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable implants, that is aimed to help the body to heal it self.

Global HQ, R&D and manufacturing is located in Uppsala, Sweden.

Address

  • TIGR® Matrix
  • Virdings Allé 2
  • SE 754 50 Uppsala
  • Our homepage